NUCLEUS
Nucleus Software Exports share price & financials
- Price
- ₹785.35
- Market cap
- ₹1.8k Cr
- Sector
- Information Technology
- Calls analysed
- 8
Nucleus Software Exports Limited Q1 FY27
What went well
- Consolidated revenue grew by 6.4% QoQ to INR 210.4 crore.
- Order book position significantly increased to INR 1,244 crore, reflecting 19.15% QoQ growth.
- Successful launch of full-blown release 9.0 with embedded AI capabilities.
What to watch
- EBITDA margin sharply declined to 3.6% from 15.4% QoQ and 15.5% YoY.
- Profit after tax degrew by 30.9% QoQ and 32.2% YoY to INR 23.9 crore.
What Nucleus Software Exports Limited does
Nucleus Software Exports Limited develops and licenses banking and lending software, primarily under the FinnOne and FinnOne Neo brands, used by banks and non-banking financial companies (NBFCs) for retail and corporate lending as well as transaction processing. Revenue comes from two lines: licensing/product sales of these platforms, and projects & services engagements covering implementation, customization, and migration for client financial institutions. The company operates from India and pursues international growth through market development efforts in Japan and a newly established subsidiary in Vietnam targeting Southeast Asia.
Segments
- Product
- Projects & Services
- New client logos added (FY26)
- 7 new logos (vs 3 in FY25)
- Sales & account management headcount added (FY26)
- 40-50 new sales executives, plus a new Chief Business Officer
- Geographic footprint
- Registered office in New Delhi, India; active market-development push in Japan; new subsidiary established in Vietnam for Southeast Asia expansion
- Product lines under active development
- Co-lending and gold loan lending capabilities
- Platform migration focus
- Ongoing migration of the client base from the legacy FinnOne platform to FinnOne Neo
Guidance record · Q1 FY27
what the last two calls moved 14 tracked 2 delivered 6 missed 6 open- Product Development delivered said Q4 FY25 Promised: bring as many as used cases into implementations Q1 FY27: Company launched release 9.0 with embedded AI capabilities and mentioned tangible progress on its enterprise AI foundation. This continues to fulfill the promise.
- Financial Performance missed said Q1 FY25 Promised: bounce back on the financial numbers also in coming quarters Q1 FY27: Financial performance deteriorated significantly, with EBITDA collapsing to INR 7.6 crore and PAT declining 32.2% YoY. The bounce back has not materialized.
- Revenue Growth at risk said Q4 FY26 Promised: robust order book is going to definitely positively impact [revenue] in positive terms for quite a few quarters Q1 FY27: In the first quarter of the lag period, revenue declined 6.4% QoQ. This is not a positive impact, putting the promise at risk.
All 14 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue down 3.7%, net profit down 31.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 202 | 206 | 229 | 218 | 214 +6% | 220 +7% | 225 −2% | 210 −4% |
| EBITDA | 32 | 33 | 74 | 34 | 23 −28% | 33 +0% | 35 −53% | 8 −76% |
| Net profit | 33 | 35 | 65 | 35 | 26 −21% | 21 −40% | 35 −46% | 24 −31% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −32.5% 1Y
1Y: ₹1,032.4 on 10 Sept 2025 → ₹696.45. High ₹1,066.8 (18 Sept 2025), low ₹686.05 (31 Jul 2026).
How the price took the results
close before → close after
- Q1 FY27
- −7.1%
- 31 Jul
- Q4 FY26
- −1.1%
- 26 May
- Q3 FY26
- −0.3%
- 11 Feb
- Q2 FY26
- −4.0%
- 10 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 11.4% a year over 3 years, FY23 to FY26. Operating margin narrowed to 14.3%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹634 Cr | ₹826 Cr | ₹832 Cr | ₹877 Cr |
| Operating profit | ₹157 Cr | ₹221 Cr | ₹168 Cr | ₹125 Cr |
| Operating margin | 24.8% | 26.8% | 20.2% | 14.3% |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹19 Cr | ₹16 Cr | ₹15 Cr | ₹16 Cr |
| Net profit | ₹128 Cr | ₹192 Cr | ₹163 Cr | ₹117 Cr |
| Net margin | 20.2% | 23.2% | 19.6% | 13.3% |
| Cash from operations | ₹50 Cr | ₹222 Cr | ₹151 Cr | ₹117 Cr |
| Free cash flow | ₹47 Cr | ₹194 Cr | ₹136 Cr | ₹89 Cr |
| ROCE | 27.0% | 32.0% | 23.0% | 17.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹29 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr |
| Reserves | ₹643 Cr | ₹467 Cr | ₹584 Cr | ₹751 Cr | ₹822 Cr | ₹881 Cr |
| Borrowings | ₹6 Cr | ₹2 Cr | ₹6 Cr | ₹5 Cr | ₹8 Cr | ₹9 Cr |
| Other liabilities | ₹206 Cr | ₹241 Cr | ₹257 Cr | ₹332 Cr | ₹373 Cr | ₹350 Cr |
| Total liabilities | ₹885 Cr | ₹737 Cr | ₹874 Cr | ₹1.1k Cr | ₹1.2k Cr | ₹1.3k Cr |
| Fixed assets | ₹50 Cr | ₹59 Cr | ₹50 Cr | ₹59 Cr | ₹77 Cr | ₹89 Cr |
| Capital work in progress | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹635 Cr | ₹480 Cr | ₹525 Cr | ₹649 Cr | ₹676 Cr | ₹644 Cr |
| Other assets | ₹200 Cr | ₹198 Cr | ₹298 Cr | ₹406 Cr | ₹477 Cr | ₹533 Cr |
| Total assets | ₹885 Cr | ₹737 Cr | ₹874 Cr | ₹1.1k Cr | ₹1.2k Cr | ₹1.3k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
What the price assumes
Growth trapTo justify its price of ₹696, this stock must grow earnings at 14% every year for 7 years. Our analysis caps realistic growth at ~-2%. At that growth it is worth ₹281 — downside of 60%.
- Growth the price implies
- 14.3% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -3.0% a year
- net profit, FY23–FY26 · EPS -2.4%
- The gap
- 0.2 pp
- -60% downside if it only repeats history
All earnings calls (8)
Read the Q1 FY27 call →Learn to analyse Nucleus Software Exports Limited
Guides on how to read this kind of business and the numbers that matter.